NEO BY E100

neo-by-e100-logo

Neo by E100 is a white-label payment platform offers transaction services of an autonomous vehicle for charging, tolls, parking slots, etc.

#People #Website #More

NEO BY E100

Social Links:

Industry:
Automotive

Founded:
2018-01-01

Address:
Warsaw, Mazowieckie, Poland

Country:
Poland

Website Url:
http://www.neo100.io

Total Employee:
11+

Status:
Active

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Domain Not Resolving Wordpress Plugins


Current Employees Featured

maksim-stayetski_image

Maksim Stayetski
Maksim Stayetski Co-Founder and CEO @ NEO by E100
Co-Founder and CEO

Founder


maksim-artiomenko_image

Maksim Artiomenko

maksim-stayetski_image

Maksim Stayetski

Official Site Inspections

http://www.neo100.io

Unable to get host informations!!!

Loading ...

More informations about "NEO by E100"

Anova Partners With NeOnc Technologies To Bring NEO100 to …

Jun 29, 2021 · CHICAGO-- ( BUSINESS WIRE )--Anova Enterprises, Inc. (Anova), an organization dedicated to accelerating promising treatments to market with its transformative …See details»

NeOnc Technologies Engages Anova Enterprises to Pursue

Mar 6, 2023 · Anova Enterprises, a clinical research organization, to prepare FDA Fast Track and Rare Pediatric Designation application for NEO100 ® for Pediatric High-Grade Gliomas …See details»

A Study of the Safety, Dosing, and Delivery of NEO100 in Patients …

This is an open label, Phase 1b safety, dose-finding, brain tumor delivery, and pharmacokinetics study of intranasal NEO100 in patients with pediatric-type diffuse high grade gliomas. Patients …See details»

NeOnc Technologies Begins Enrollment for Phase 2 Clinical Trial of ...

Aug 5, 2024 · NeOnc’s second concurrent Phase 2 clinical study seeks further safety and preliminary evidence of biological effects of its lead drug candidate, NEO100 â„¢, on certain …See details»

support.neo100.io

You need to enable JavaScript to run this app. You need to enable JavaScript to run this app.See details»

NeOnc Technologies Begins Enrollment for Phase 2 Clinical

Aug 5, 2024 · NeOnc’s second concurrent Phase 2 clinical study seeks further safety and preliminary evidence of biological effects of its lead drug candidate, NEO100 â„¢, on certain …See details»

NEO100 and High-Grade Meningioma - NCI - National Cancer …

This multi-site, Phase 2 clinical trial is an open-label study to identify the safety, pharmacokinetics, and efficacy of a repeated dose regimen of NEO100 (perillyl alcohol) for the treatment of …See details»

NeOnc initiates Phase 2 trial of NEO100 intranasal perillyl alcohol …

Aug 6, 2024 · NeOnc Technologies has announced the initiation of a Phase 2 trial of NEO100 intranasal perillyl alcohol in patients with tumors of the membranes surrounding the brain …See details»

NEO100 and High-Grade Meningioma - ICH GCP

Aug 20, 2021 · Meningiomas can be organized into two groups. WHO Grade I meningioma are histologically benign and can be managed by careful observation as recommended in the …See details»

Neo By E100 Sp. z o.o. (Poland) - EMIS

Jun 6, 2024 · Report with financial data, key executives contacts, ownership details & and more for Neo By E100 Sp. z o.o. in Poland. Report is available for immediate purchase & download …See details»

NeOnc Technologies Receives FDA Approval to Expand

Jul 16, 2024 · NeOnc’s NEO100â„¢ and NEO212â„¢ therapeutics are in Phase I and II human clinical trials, and are advancing under FDA Fast-Track and Investigational New Drug (IND) …See details»

NeOnc Technologies Begins Enrollment for Phase 2 Clinical Trial of ...

NeOnc Technologies Holdings, Inc. has begun patient enrollment for the Phase 2 clinical trial of NEO100-02, the company’s first of two drug candidates proceeding through four concurrent …See details»

NEO100 Brings Hope to Glioblastoma Patients

Jan 16, 2024 · Currently in a phase 2 clinical trial, NEO100 is a groundbreaking new drug used for the treatment of glioblastoma, a rare and aggressive form of brain cancer with no current FDA …See details»

NeOnc Technologies begins Phase l/lla clinical trial of NEO100 to …

May 15, 2016 · US-based, biotechnology company NeOnc Technologies has begun a multi-centre Phase l/lla clinical trial of NEO100 to treat recurrent glioblastoma multiforme (GBM), with the …See details»

Phase I trial of intranasal NEO100, highly purified perillyl alcohol ...

Feb 12, 2021 · NEO100, a highly purified version of POH, was current good manufacturing practice (cGMP) manufactured to evaluate the safety and efficacy of this novel approach in a …See details»

NeOnc Technologies Begins Enrollment for Phase 2 Clinical

Aug 5, 2024 · NeOnc’s second concurrent Phase 2 clinical study seeks further safety and preliminary evidence of biological effects of its lead drug candidate, NEO100 â„¢, on certain …See details»

Phase I trial of intranasal NEO100, highly purified perillyl alcohol ...

Feb 12, 2021 · Intranasal NEO100 represents a novel approach to brain cancer therapy and has the potential to become clinically useful to improve treatment outcomes for recurrent …See details»

NEO by E100 - Crunchbase Company Profile & Funding

Neo by E100 is a white-label payment platform offers transaction services of an autonomous vehicle for charging, tolls, parking slots, etc. There is no recent news or activity for this profile. …See details»

International Organization | Cambridge Core

International Organization (IO) is a leading peer-reviewed journal that covers the entire field of international affairs. IO features articles that propose generalizable theories, improve social …See details»

Failed to login to registry docker.io - Questions and Answers

2 days ago · Hello @David_Armour and thanks for the report.. The issue should be fixed, there was a problem with our internal dockerhub credentials, you can retry your deployment. …See details»